A team of researchers at the University of Oxford have unveiled a pioneering “microstent” which could revolutionize treatment for glaucoma, a common but debilitating condition. The study has been published in The Innovation.
By analyzing millions of messenger RNA molecules (mRNA) during the course of ALS, researchers at Stockholm University, in collaboration with scientists at the Paris Brain Institute and Örebro University, have identified why certain nerve cells are resistant to the disease and what happens in the sensitive nerve cells when they are affected.
A research project has reached an important milestone: the first treatment of an animal tumor with radioactive ion beams has been demonstrated and published in Nature Physics.
Our sense of smell is more important than we often realize. It helps us enjoy food, detect danger like smoke or gas leaks, and even affects our memory and emotions. Many people—especially after COVID-19, aging, or brain injury—suffer from a loss of smell. However, there are very few effective treatments, and those that exist often use strong scents or medicines that cause discomfort in patients.
BUSAN, South Korea, Aug. 19, 2025 /PRNewswire/ — Cerebrovascular diseases, including atherosclerosis and stroke, remain a major global health concern. A common feature of these diseases is vascular stenosis—the narrowing of blood vessels—which disrupts normal blood flow and contributes to chronic inflammation in vessel walls
Two studies led by Johns Hopkins Kimmel Cancer Center, Ludwig Center, and Johns Hopkins Whiting School of Engineering researchers report on a powerful new method that significantly improves the reliability and accuracy of artificial intelligence (AI) for many applications.
BURLINGTON, N.C., Aug. 18, 2025 /PRNewswire/ — Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the availability of the Lumipulse® pTau-217/Beta Amyloid 42 Ratio, the first blood-based in-vitro diagnostic (IVD) test cleared by the U.S. Food and Drug Administration (FDA) to aid in the diagnosis of Alzheimer’s disease.
The company is collaborating with local companies and healthcare providers to distribute the ulcer test.
A Medical University of South Carolina team reports in Frontiers in Immunology that it has engineered a new type of genetically modified immune cell that can precisely target and neutralize antibody-producing cells complicit in organ rejection.
Swansea University has helped uncover a surprising new role for platelets—one that could significantly advance early cancer detection.